Show simple item record

dc.contributor.authorAlatwi, HE
dc.contributor.authorDowns, JA
dc.date.accessioned2020-07-24T15:04:26Z
dc.date.issued2015-08-01
dc.identifier.citationEMBO reports, 2015, 16 (8), pp. 986 - 994
dc.identifier.issn1469-221X
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3868
dc.identifier.eissn1469-3178
dc.identifier.doi10.15252/embr.201540330
dc.description.abstractThe mammalian INO80 remodelling complex facilitates homologous recombination (HR), but the mechanism by which it does this is unclear. Budding yeast INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B dimers. H2A.Z is actively incorporated at sites of damage in mammalian cells, raising the possibility that H2A.Z may need to be subsequently removed for resolution of repair. Here, we show that H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80. We also report that the histone chaperone ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80 in these assays. Importantly, we demonstrate that the HR defect in cells depleted of INO80 or ANP32E can be rescued by H2A.Z co-depletion, suggesting that H2A.Z removal from chromatin is the primary function of INO80 and ANP32E in promoting homologous recombination.
dc.formatPrint-Electronic
dc.format.extent986 - 994
dc.languageeng
dc.language.isoeng
dc.publisherWILEY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectCell Line, Tumor
dc.subjectHela Cells
dc.subjectChromatin
dc.subjectHumans
dc.subjectDNA Damage
dc.subjectDNA Helicases
dc.subjectMolecular Chaperones
dc.subjectNuclear Proteins
dc.subjectHistones
dc.subjectPhosphoproteins
dc.subjectRNA, Small Interfering
dc.subjectChromatin Assembly and Disassembly
dc.subjectDNA Repair
dc.subjectGene Knockdown Techniques
dc.subjectHomologous Recombination
dc.titleRemoval of H2A.Z by INO80 promotes homologous recombination.
dc.typeJournal Article
dcterms.dateAccepted2015-06-10
rioxxterms.versionofrecord10.15252/embr.201540330
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2015-08
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEMBO reports
pubs.issue8
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Epigenetics and Genome Stability
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Epigenetics and Genome Stability
pubs.publication-statusPublished
pubs.volume16
pubs.embargo.termsNot known
icr.researchteamEpigenetics and Genome Stability
dc.contributor.icrauthorDowns, Jessica


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0